1 |
Floyd RA, Hensley K, Bing G. 2000. Evidence for enhanced neuro-inflammatory processes in neurodegenerative disease and the action of nitrones as potential therapeutics. Adv Res Neurodegen 8: 387-414.
|
2 |
Gschwind M, Huber G. 1995. Apoptotic cell death induced by beta-amyloid peptide is cell type dependent. J Neurochem 65: 292-300.
|
3 |
Feng Z, Zhang JT. 2004. Protective effect of melatonin on beta-amyloid induced apoptosis in rat astroglioma C6 cells and its mechanism. Free Radic Biol Med 37: 1790-1801.
DOI
ScienceOn
|
4 |
Hensley K, Aksenova M, Carney JM, Butterfield DA.1995. Amyloid-beta peptide spin trapping II. Neuroreport 6: 489-493.
DOI
ScienceOn
|
5 |
Nowen DM, Francis PT, Sims NR. 1992. Beta-amyloid increased neuronal susceptibility to injury by glucose deprivation.Neuroreport 3: 733-734.
DOI
ScienceOn
|
6 |
Klegeris A, McGeer PL. 1997. Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J Neurosci Res 49: 229-235.
DOI
ScienceOn
|
7 |
Shearman MS, Ragan CI, Iversen LL. 1994. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci USA 91: 1470-1474.
DOI
ScienceOn
|
8 |
Loo DT, Copani A, Pike CJ, Whittemore EK. 1993. Apoptosis is induced by beta-amyloid in cultured nervous system neurons. Proc Natl Acad Sci USA 90: 7951-7955.
DOI
|
9 |
Loo DT, Copani A, Pike CJ, Whittemore EK. 1993. -Apoptosis is induced by beta-amyloid in cultured nervous system neurons. Proc Natl Acad Sci USA 90: 7951-7955.
DOI
|
10 |
Salvessen GS, Dixit VM. 1997. Caspases, intracellular signaling by proteolysis. Cell 91: 443-446.
DOI
ScienceOn
|
11 |
Nicholson DW, Thornberry NA. 1997. Caspases: killer proteases. Trends Biochem Sci 22: 299-306.
DOI
ScienceOn
|
12 |
Perry G, Nunomura A, Cash AD, Taddeo MA. 2002. Reactive oxygen: Its sources and significance in Alzheimer disease. J Neural Transmis Suppl 62: 69-75.
DOI
|
13 |
Miranda S, Opazo C, Larrondo LF, Munoz FJ. 2000. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer’s disease. Prog Neurobiol 62: 633-648.
DOI
ScienceOn
|
14 |
Behl C, Davis JB, Lesley R, Schubert D. 1994. Hydrogen peroxide mediates amyloid-beta protein toxicity. Cell 77:817-827.
DOI
ScienceOn
|
15 |
Debrenner B, Meier B. 1998. Petasites hybridus: a tool for interdisciplinary research in phytotheraphy. Pharm Acta Helv 72: 359-380.
DOI
ScienceOn
|
16 |
Hasa Y, Tazaki H. 2004. Biosynthesis of fukinolic acid isolated from Petasites japonica. Biosci Biotechnol Biochem 68: 2212-2214.
DOI
ScienceOn
|
17 |
Lin CH, Li CY, Wu TS. 2004. A novel phenylpropenoyl sulfonic acid and a new chlorophyll from the leaves of Petasites formosanus KITAMURA. Chem Pharm Bull 52:1151-1152.
|
18 |
Sok DE, Oh SH, Kim YB, Kang HG. 2006. Neuroproection by extract of japonicus leaves, a traditional vegetable, against oxidative stress in brain of mice challenged with kainic acid. Eur J Nutr 45: 61-69.
DOI
|
19 |
Song KS, Choi SH, Hur JM, Park HJ, Yang EJ, Mook-Jung I, Yi JH, Jun M. 2008. Inhibitory effects of flavonoids isolated from leaves of Petasites japonicus on -secretase (BACE1). Food Sci Biotechnol 17: 1165-1170.
|
20 |
Ban JY, Jeon SY, Nguyen TTH, Bae K. 2006. Neuroprotective effect of oxyresveratrol from Smilacis Chinae Rhizome of amyloid beta-protein (25-35) induced neurotoxicity in cultured rat cortical neurons. Biol Pharm Bull29: 2419-2424.
DOI
ScienceOn
|
21 |
Mosman T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Meth 65: 53-63.
|
22 |
Jang JH, Surh YJ. 2003. Protective effect of resveratrol on beta-amyloid induced oxidative PC12 cell death. Free Radic Biol Med 34: 1100-1110.
DOI
ScienceOn
|
23 |
Selkoe DJ. 1994. Normal and abnormal biology of the -amyloid precursor protein. Annu Rev Neurosci 17: 489-517.
DOI
ScienceOn
|
24 |
Glenner GG, Wong CW. 1984. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890.
DOI
ScienceOn
|
25 |
Citron M. 2004. Strategies for disease modification in Alzheimer’s disease. Nat Rev Neurosci 5: 677-685.
DOI
ScienceOn
|